Aspire Biopharma, Inc. (NASDAQ:PWUP) | WebDisclosure

Basculer en Français

8621	Companies
142891	Keywords
78626	Articles
76348	Press releases

Headlines Articles Press releases Aspire Biopharma, Inc.

Home
Companies
Aspire Biopharma, Inc.

BRIEF

published on 04/14/2025 at 14:35, 6 days 9 hours ago

Aspire Biopharma participera à la conférence Emerging Growth

Conférence Sur La Croissance Émergente Approbation De La FDA Aspire Biopharma Aspirine À Haute Dose Étude Clinique De Phase 1
BRIEF

published on 04/14/2025 at 14:35, 6 days 9 hours ago

Aspire Biopharma to Present at Emerging Growth Conference

FDA Approval Emerging Growth Conference Phase 1 Clinical Study Aspire Biopharma High-dose Aspirin
PRESS RELEASE

published on 04/14/2025 at 14:30, 6 days 10 hours ago

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) to present at the Emerging Growth Conference on April 17, 2025, showcasing their patent-pending drug delivery technology

Emerging Growth Conference Clinical Trial Drug Delivery Patent-pending Technology Aspire Biopharma
BRIEF

published on 04/11/2025 at 14:35, 9 days 9 hours ago

Aspire Biopharma lance la production d'un complément pré-entraînement

Technologie Sublinguale Marché Du Fitness Aspire Biopharma Supplément Pré-entraînement Tests Consommateurs
BRIEF

published on 04/11/2025 at 14:35, 9 days 9 hours ago

Aspire Biopharma Begins Production of Pre-Workout Supplement

Sublingual Technology Fitness Market Aspire Biopharma Pre-workout Supplement Consumer Testing
PRESS RELEASE

published on 04/11/2025 at 14:30, 9 days 10 hours ago

Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement
Aspire Biopharma initiates production of new pre-workout supplement with innovative technology and plans consumer testing. Increasing demand for fitness supplements drives growth

Health And Wellness Industry Aspire Biopharma Pre-workout Supplement Consumer Testing Fitness Supplements
BRIEF

published on 04/09/2025 at 14:35, 11 days 9 hours ago

Aspire Biopharma Initiates Phase 1 Trial for High-Dose Aspirin

Phase 1 Trial FDA Fast Track Aspire Biopharma High-dose Aspirin Sublingual Formulation
BRIEF

published on 04/09/2025 at 14:35, 11 days 9 hours ago

Aspire Biopharma lance un essai de phase 1 pour l'aspirine à haute dose

Procédure Accélérée De La FDA Essai De Phase 1 Aspire Biopharma Aspirine À Haute Dose Formulation Sublinguale
PRESS RELEASE

published on 04/09/2025 at 14:30, 11 days 10 hours ago

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Aspire initiates Phase 1 trial for high-dose aspirin formulation to target acute myocardial infarction. Trial to evaluate safety, pharmacokinetics, pharmacodynamics, with fast track FDA application

FDA Approval Phase 1 Trial Aspire High-dose Aspirin Acute Myocardial Infarction
BRIEF

published on 03/20/2025 at 13:35, 1 month ago

Aspire Biopharma Advances Aspirin Product Development

FDA Approval Clinical Trials Aspire Biopharma GMP Aspirin Fast Acting Formulation

Accesswire

Published on 04/18/2025 at 23:35, 2 days ago

urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Published on 04/18/2025 at 01:20, 2 days 23 hours ago

Aston Bay Files Technical Report for Storm Copper Project Initial Mineral Resource Estimate
Published on 04/18/2025 at 00:42, 2 days 23 hours ago

Regency Silver Announces New CEO
Published on 04/18/2025 at 00:00, 3 days ago

Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Published on 04/17/2025 at 23:50, 3 days ago

Fourth Quarter and Year-End 2024 Results

View all ACCESSWIRE

EQS Group

Published on 04/18/2025 at 18:00, 2 days 6 hours ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25.
Published on 04/18/2025 at 18:00, 2 days 6 hours ago

E-PANGO: Résultats annuels 2024
Published on 04/18/2025 at 17:54, 2 days 6 hours ago

VALBIOTIS SA: Compte-rendu de l’Assemblée générale mixte du 18 avril 2025
Published on 04/18/2025 at 17:52, 2 days 6 hours ago

Market entry in France – Cicor acquires significant business activities of Éolane
Published on 04/18/2025 at 17:45, 2 days 6 hours ago

Linedata Services: Déclaration des transactions sur actions propres opération du 16 avril 2025

Les Echos

Published on 04/18/2025 at 17:45, 2 days 6 hours ago

Saint-Gobain once again featured on CDP’s “Climate A List”
Published on 04/18/2025 at 17:45, 2 days 6 hours ago

Saint-Gobain figure une nouvelle fois sur la « Climate A List » établie par le CDP
Published on 04/18/2025 at 11:16, 2 days 13 hours ago

Déclaration hebdomadaire d'opérations effectuées du 14 au 17 avril 2025
Published on 04/18/2025 at 11:16, 2 days 13 hours ago

Disclosure of transactions in own shares from April 14 to April 17, 2025
Published on 04/18/2025 at 07:00, 2 days 17 hours ago

Uitnodiging voor de Jaarvergadering en Buitengewone Algemene Vergadering van aandeelhouders

View all LES ECHOS COMFI WIRE